HMS
VRTX icon

Hanseatic Management Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Hanseatic Management Services’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,667
Closed -$580K – 142
2023
Q3 		$580K Buy
1,667
+1
+0.1% +$350 1.08% 27
2023
Q2 		$586K Sell
1,666
-14
-0.8% -$4.72K 1.08% 27
2023
Q1 		$529K Sell
1,680
-24
-1% -$7.2K 1.19% 28
2022
Q4 		$492K Sell
1,704
-23
-1% -$7.01K 1.25% 26
2022
Q3 		$500K Sell
1,727
-38
-2% -$10.9K 1.35% 22
2022
Q2 		$497K Buy
+1,765
New +$472K 1.13% 27
2020
Q4 		– Sell
-365
Closed -$99K – 214
2020
Q3 		$99K Sell
365
-2,584
-88% -$713K 0.22% 67
2020
Q2 		$856K Buy
2,949
+2,668
+949% +$723K 0.72% 49
2020
Q1 		$67K Hold
281
– – 0.07% 131
2019
Q4 		$62K Hold
281
– – 0.06% 147
2019
Q3 		$48K Hold
281
– – 0.05% 134
2019
Q2 		$52K Sell
281
-17
-6% -$2.97K 0.05% 140
2019
Q1 		$55K Hold
298
– – 0.06% 140
2018
Q4 		$49K Buy
298
+102
+52% +$17.7K 0.07% 130
2018
Q3 		$38K Hold
196
– – 0.04% 196
2018
Q2 		$33K Sell
196
-4,913
-96% -$762K 0.03% 199
2018
Q1 		$833K Buy
5,109
+17
+0.3% +$2.78K 0.8% 39
2017
Q4 		$763K Buy
5,092
+419
+9% +$62K 0.77% 45
2017
Q3 		$710K Sell
4,673
-261
-5% -$39.3K 0.81% 43
2017
Q2 		$636K Buy
+4,934
New +$594K 0.32% 118
2015
Q4 		– Sell
-6,000
Closed -$625K – 402
2015
Q3 		$625K Buy
+6,000
New +$771K 0.19% 161
2015
Q1 		– Sell
-16,849
Closed -$2M – 387
2014
Q4 		$2M Buy
16,849
+147
+0.9% +$16.6K 1.03% 26
2014
Q3 		$1.88M Buy
+16,702
New +$1.59M 1% 25

Other funds holding VRTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hanseatic Management Services's VRTX Position: Q4 2023 in Review

Hanseatic Management Services sold out of Vertex Pharmaceuticals (VRTX) in Q4 2023, closing a stake of 1,667 shares — an estimated $580K sold.

Hanseatic Management Services first reported a position in VRTX in Q3 2014 and held it in 23 quarters. The position peaked at $2M in Q4 2014. 1,438 funds tracked by Wall St. Rank hold VRTX as of Q4 2023.

  • Hanseatic Management Services reported no remaining Vertex Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Hanseatic Management Services sold 1,667 Vertex Pharmaceuticals shares in Q4 2023, an estimated $580K.
  • Hanseatic Management Services first reported a position in Vertex Pharmaceuticals in Q3 2014 and held it in 23 quarters.
  • Hanseatic Management Services's Vertex Pharmaceuticals position peaked at $2M in Q4 2014.
  • 1,438 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2023.

Based on Hanseatic Management Services's 13F filing for Q4 2023, filed 15 Feb 2024.